BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25346009)

  • 1. Genomic medicine for cancer diagnosis.
    Gordon BL; Finnerty BM; Aronova A; Fahey TJ
    J Surg Oncol; 2015 Jan; 111(1):24-30. PubMed ID: 25346009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primer on medical genomics. Part VI: Genomics and molecular genetics in clinical practice.
    Ansell SM; Ackerman MJ; Black JL; Roberts LR; Tefferi A
    Mayo Clin Proc; 2003 Mar; 78(3):307-17. PubMed ID: 12630584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethics and genomic medicine, how to navigate decisions in surgical oncology.
    Devon KM; Lerner-Ellis JP; Ganai S; Angelos P
    J Surg Oncol; 2015 Jan; 111(1):18-23. PubMed ID: 25183289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical and legal aspects of oncogenomics.
    Stankov K; Draskovic D; Mikov M
    J BUON; 2012; 17(2):383-8. PubMed ID: 22740222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal Genomic Testing Needed to Win the War Against Cancer: Genomics IS the Diagnosis.
    Subbiah V; Kurzrock R
    JAMA Oncol; 2016 Jun; 2(6):719-20. PubMed ID: 27078832
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA-based diagnosis of hereditary tumour predisposition].
    Menko FH; Ligtenberg MJ; Brouwer T; Hahn DE; Ausems MG
    Ned Tijdschr Geneeskd; 2007 Feb; 151(5):295-8. PubMed ID: 17326472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction: molecular genomics of cancer: linking diagnostic testing and clinical therapy.
    Fisher KE; Neill SG; Smith GH; Pillai RN; Kudchadkar RR; Zhang L; Rossi MR
    Curr Probl Cancer; 2014; 38(5):142-3. PubMed ID: 25220586
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecule based diagnosis].
    Akaza H; Ichikawa T; Tsuruo T; Shimada Y; Moriwaki H; Mori M; Noguchi S; Nakamura S; Saijo N; Sone S; Isonishi S; Ohashi Y; Hinotsu S; von Euler M; Blackedge G
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):125-33. PubMed ID: 14750337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized oncology: genomic screening in phase 1.
    Tuxen IV; Jønson L; Santoni-Rugiu E; Hasselby JP; Nielsen FC; Lassen U
    APMIS; 2014 Aug; 122(8):723-33. PubMed ID: 25046202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Oncology in the Age of Genomic Medicine.
    Weber TK
    Surg Oncol Clin N Am; 2015 Oct; 24(4):xiii-xv. PubMed ID: 26363545
    [No Abstract]   [Full Text] [Related]  

  • 14. Next generation sequencing applications in cancer research.
    Zhang W; Nykter M; Chen K
    Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum ferritin in Nigerian patients with Burkitt's lymphoma and other malignant diseases.
    Bolarin DM
    Acta Trop; 1983 Mar; 40(1):71-7. PubMed ID: 6134456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical selection of candidates for mutational testing for cancer susceptibility.
    Lynch HT; Lynch PM
    Oncology (Williston Park); 2006 Dec; 20(14 Suppl 10):29-34. PubMed ID: 17354515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence for expanded genetic testing for pediatric patients with cancer.
    Maese L; Schiffman JD
    Future Oncol; 2018 Feb; 14(3):187-190. PubMed ID: 29327612
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
    Papadopoulos N; Kinzler KW; Vogelstein B
    Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].
    Sebastian M; Niederle N; Thomas M; Reck M; Schmittel A; Fischer B; Overbeck T; Gröschel A; Deppermann M; Pirker R; Huber RM; Eberhardt W; Griesinger F
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2096-100. PubMed ID: 25268213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
    Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
    Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.